Stay updated on Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was incremented from **v3.5.2** to **v3.5.3**.
    Difference
    0.0%
    Check dated 2026-04-24T06:15:33.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:43:28.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:16:02.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and deleted Revision: v3.4.2 in the page’s version history. This is a minor update that does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-03-12T01:03:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new site in Ciudad de Buenos Aires, Argentina (C1120AAT) was added on 2026-02-27, and the Buenos Aires, Argentina site was removed on 2025-10-28.
    Difference
    0.3%
    Check dated 2026-03-04T23:47:48.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the page removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:21:39.000Z thumbnail image

Stay in the know with updates to Savolitinib Combo in EGFRm+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib Combo in EGFRm+ NSCLC Clinical Trial page.